i3 Health and Oncology Data Advisor Announce ODACon 2022, a Rare Hematologic Malignancies Symposium

ROCHELLE PARK, NJ—January 12, 2022 – i3 Health and Oncology Data Advisor have announced that ODACon, a Rare Hematologic Malignancies Symposium, will be held on January 29, 2022. This 1-day virtual conference features 5 exclusive sessions on emerging data in hematologic malignancies, including acute lymphoblastic leukemia (ALL), Hodgkin lymphoma (HL), mantle cell lymphoma (MCL), myelodysplastic syndromes (MDS), and Waldenstrom macroglobulinemia (WM), all presented by expert faculty. Attendees can...

Continue reading

i3 Health Publishes T-Cell Lymphoma Education Study in American Society of Hematology Online Program

i3 Health's study focusing on the effectiveness of an online continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity to improve clinicians' knowledge of therapeutic advances in T-cell lymphoma (TCL) has been published as a 63rd American Society of Hematology (ASH) Annual Meeting & Exposition online abstract

Continue reading

Oncology Data Advisor Announces Formation of Editorial Board

ROCHELLE PARK, NJ––September 28, 2021 – Oncology Data AdvisorTM, a multimedia site that publishes expert perspectives, news, and original research to foster improved understanding of emerging data in oncology, has announced the addition of an editorial board that will help plan and create relevant content for the multidisciplinary cancer care team.

Continue reading


Get the latest updates delivered to your inbox!

Follow Us

Copyright © 2022 Oncology Data Advisor. All rights reserved.